Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
182.1 USD | +0.97% | +2.59% | +17.51% |
Mar. 27 | Barclays Raises AbbVie Price Target to $195 From $185, Maintains Overweight Rating | MT |
Mar. 25 | Deals of the day-Mergers and acquisitions | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.51% | 319B | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B | |
-1.28% | 153B |
- Stock
- Equities
- Stock AbbVie Inc. - Nyse
- News AbbVie Inc.
- AbbVie's Inflammatory Bowel Disease Drug Wins UK Approval